Google Ads for Hormone Clinics: Campaigns That Convert Without Getting Disapproved

Google Ads for hormone clinics come down to two questions: do you prescribe through telemedicine, and do you want to bid on prescription drug terms as keywords? Since October 29, 2025, Google allows promotional use of prescription drug terms in ad text and landing pages for campaigns targeting the United States, under local law. Keyword targeting of those terms still requires certification, and so do telemedicine providers.

That is narrower than the "Google bans hormone ads" advice that circulates. It is also wider than "just write around the drug names." Your answers to the two questions give you a map, and the HRT search surge guide covers the demand behind it.

I read each Google, FDA, and LegitScript page cited below on October 28, 2026. Google's policy pages show no "last updated" date, so recheck before you spend.

Key Takeaways

• The October 2025 update changed the drug-name rule. For campaigns targeting the U.S., Google says you may use prescription drug terms for promotional purposes under local laws and regulations. Certification is not needed in ads and landing pages unless you are an online pharmacy, telemedicine provider, or manufacturer.
• Keyword-targeting those terms requires certification, and so does being an online pharmacy, telemedicine provider, or pharmaceutical manufacturer.
• Telemedicine is the dividing line. Google allows U.S. telemedicine providers accredited by LegitScript's Healthcare Merchant Certification Program, and its October 2025 update adds certification for telemedicine providers. An in-person clinic is a different case from a prescribing platform.
• Testosterone is a Schedule III controlled substance, which raises state licensing and targeting stakes, and Google's unauthorized pharmacy rules say targeting locations where you aren't licensed is not allowed.
• Women's HRT and men's TRT need separate campaigns with different keywords, copy, and risk review.
• Health is a sensitive category for audiences. Customer Match and advertiser-curated remarketing are off the table.

The Two Questions That Decide Your Account

Before structure, bids, or copy, answer these two questions in writing.

Question 1: Do you prescribe or dispense through a telemedicine platform? Google's Healthcare and medicines policy restricts the promotion of services related to online prescribing, dispensing, and sale of prescription drugs, and it allows U.S. telemedicine providers that are accredited by LegitScript's Healthcare Merchant Certification Program.

Question 2: Do you want prescription drug terms as keywords? Under the October 2025 update, certification is required to keyword-target these terms in the U.S., Canada, and New Zealand.

The policy page does not define what "certification" means for keyword targeting, and it does not name a certifying body for that purpose. Ask your Google representative or use Google's own certification form before you build a campaign around drug-name keywords. Search Engine Roundtable quoted Google's Ads Liaison saying the approach to keyword targeting in this area "remains the same".

The two Google pages do not fully line up. Google's main Healthcare and medicines page still says that, depending on location, advertisers may be able to use these terms to promote prescription drugs, and it points to location-specific rules. The October 2025 update page says certification is not needed for ads and landing pages in the United States, Canada, and New Zealand. I treat the newer update page as governing for those countries.

What Changed in October 2025, and Why Older Advice Is Stale

Some agency pages still say drug names, dosing, and brands in ads are disapproved. That was closer to the old rule. The October 2025 update, posted October 14 with enforcement starting October 29, moved the line.

Here is the current text from Google's update page.

• For campaigns targeting Canada, New Zealand, or the United States: "You may use prescription drug terms for promotional purposes, in accordance with local laws and regulations."
• Certification is not needed to use these terms in ads and landing pages, but "you must be certified in order to keyword-target these terms."
• Certification is also required for online pharmacies, telemedicine providers, and pharmaceutical manufacturers.
• Google says it will warn at least 7 days before any suspension for violations of the updated rule.

Two cautions keep this from turning into a green light.

First, "in accordance with local laws" does the heavy lifting. A claim that is false, unsubstantiated, or unlawful in your state is still a problem.

Second, Google does not publish the term list on the pages I read. I do not know which hormone terms count as "prescription drug terms." Treat hormone names as in scope until a small test tells you otherwise.

Testosterone Raises the Stakes

Testosterone is listed in the Controlled Substances Act's Schedule III. The federal schedule at 21 CFR 1308.13 lists testosterone in the anabolic steroids paragraph. That puts state licensing, prescribing rules, and recordkeeping on your side of the table before an ad runs.

For ads, the practical rule comes from Google's unauthorized pharmacy rules, which state that targeting locations where you aren't licensed is not allowed. Match geographic targeting to the states where your prescribers hold licenses and where your service model is lawful.

Other hormone-adjacent products have their own lines on that policy page.

• hCG is prohibited when promoted for weight loss or weight control, and when promoted with anabolic steroids.
• DHEA is prohibited except in campaigns targeting the United States.
• Google's separate list of unapproved pharmaceuticals and supplements is "not an exhaustive list," and includes anabolic-steroid-style product names.

If your menu includes peptides, compounded hormones, or growth hormone products, take those to counsel before they touch an ad or landing page. I have not found a Google page that settles them, and the downside of a wrong guess is account-level.

Separate Women's HRT and Men's TRT Campaigns

The HRT search surge guide explains why women and men are separate marketing problems. Ads sharpen that split because the risk differs too.

Keep budgets, ad copy, landing pages, and negative keyword lists separate. When one campaign gets reviewed, the other should not wait behind it.

Google Ads Campaign Structure for Hormone Clinics

Rule-heavy systems reward structure, and policy exposure is a design problem, so I design the account around it. Here is the structure I would build.

1. Separate accounts by business model only when the business is separate. Do not split one clinic into several accounts to dodge a disapproval. Use campaigns and ad groups.
2. One campaign per audience (women's HRT, men's TRT), each with its own geographic targets matched to licensure.
3. Ad groups by symptom cluster, as the HRT guide lays out: brain fog, sleep disruption, low energy, low libido, metabolism changes.
4. A consultation-intent ad group for "hormone clinic [city]" and "hormone doctor near me" style terms.
5. A drug-term ad group, only if you are certified and your counsel agrees. Keep it separate so a policy problem there does not touch the rest.
6. Search campaigns first. Intent comes from the query, which matters more here than anywhere else in your account.
7. Conversion tracking on booked consultations, with a phone number and form each tracked separately.

Symptom keywords carry the volume

In my judgment, symptom searches carry lower policy risk and match the way patients start: brain fog, sleep problems, low energy. The hormone clinic SEO guide covers the organic side of the same symptom clusters. Use the two together, with ads on the high-intent symptom and local terms and organic on the research phase.

Match types and starter negatives

These are my drafting suggestions, not Google guidance. Start symptom and consultation terms on phrase and exact match, and hold broad match back until the search terms report shows clean queries. Test negatives such as "supplements," "online prescription," "free," "jobs," and "DIY" in the first week, then grow the list from real queries.

Writing Ad Copy That Survives Review

These are my drafting rules for hormone ad copy. They are conservative on purpose, and none of them come from a Google list of disapproved phrases.

Sources: Google's Misrepresentation policy and the FTC's health products compliance guidance.

The FTC guidance adds that a results-may-vary disclaimer does not repair a testimonial that overstates typical results. If a headline needs a disclaimer to be honest, rewrite the headline.

Audience and Remarketing Limits

Health is a sensitive interest category in Google's personalized advertising policy. Advertisers in these categories cannot use advertiser-curated audiences, and Customer Match is not supported.

That removes two habits clinics rely on. You cannot upload a lead list to find similar people, and you cannot remarket to site visitors with a custom list. Predefined Google audiences, location targeting, and demographics remain available.

Use that limit as a reason to invest in the parts you do control: follow-up on every lead, email nurture to people who opted in, and reviews. The AI systems service covers lead follow-up automation for exactly this gap.

Landing Pages and Measurement

A hormone ad lands on a page that must do two jobs: convert a researching patient and show a reviewer a legitimate clinic.

• Clinician and credentials above the fold, with license details your counsel is comfortable publishing.
• Location and contact details, consistent with your Google Business Profile listing.
• A plain-language description of the evaluation, covering what labs, what visit, and what happens next.
• One booking path, with the phone number and form tracked separately.
• Safety and risk language that your clinician reviewed.

Measure booked consultations and the cost of each. In my experience a click is a weak signal in a category where patients research for weeks. I will not quote CPC or cost-per-lead ranges, because I could not open a primary source for them. Pull them from your own account after 60 days.

When Ads Are the Wrong Channel

Some clinics should lead with organic. Three cases point that way. You prescribe by telehealth without certification, your menu leans on peptides or other products the policy pages restrict, or your budget cannot fund a 60-day test. In those cases the money is better spent on search and AI visibility and local SEO. Ads work best as a layer on top of a base that converts, and they amplify a leaky one.

The AI SEO service covers building that base.

A Launch Checklist

1. Write down your model: in-person, telehealth, or hybrid.
2. Confirm licensure by state and match geographic targeting to it.
3. If you prescribe through telehealth, start LegitScript certification before you build anything.
4. Decide whether drug-term keywords are worth certification for your market.
5. Build women's and men's campaigns separately.
6. Write ad copy from the lower-risk column above.
7. Build one evaluation landing page per audience.
8. Track booked consultations by source.
9. Save dated copies of every policy page you relied on.
10. Review search terms weekly for the first 60 days.

Your Next Step

Today, write down your model (in-person, telehealth, or hybrid) and answer the two questions from the top of this guide in one paragraph. If you prescribe by telehealth, start the LegitScript application the same week.

Questions practice owners ask

Can hormone clinics run Google Ads at all?

Yes, with conditions. Google allows prescription drug terms in ads and landing pages for U.S. campaigns under local law, with no certification needed unless you are an online pharmacy, telemedicine provider, or manufacturer. Telemedicine providers need LegitScript accreditation, and keyword-targeting drug terms requires certification.

Do I need LegitScript certification?

If you prescribe through telemedicine, Google says U.S. providers must be accredited by LegitScript's Healthcare Merchant Certification Program. LegitScript's healthcare page lists licensure, legal compliance, and accurate advertising among its standards. An in-person clinic is not described by that rule.

Can I put "testosterone" in my ad copy?

Google's October 2025 update allows promotional use of prescription drug terms in U.S. ad text under local law. The page does not list which terms count, and testosterone is a controlled substance, so involve counsel and test with a small campaign first.

Why were my hormone ads disapproved?

Read the exact policy in the notice. Common categories are outcome claims, prescribing language without accreditation, targeting outside licensed states, and unapproved products. Fix the destination as well as the ad.

Should I bid on "HRT near me"?

It is a reasonable local term, and it is a broad one. Pair it with symptom-specific groups that convert closer to booking, and review the search terms report weekly.

How is this different from the hormone SEO plan?

SEO owns the research phase and the local pack over time. Ads capture patients ready to book now. Run them together once your landing pages convert.

Mike Kohl, founder of Health Biz Scale | Policy pages read October 28, 2026

This guide is general information, not legal or regulatory advice. Controlled substance and telemedicine rules vary by state. Confirm requirements with a qualified healthcare attorney before launching.